New Cancer Imaging Network is Developed

Cancer Imaging

Recently, the news about an integrated network for standardizing and validating the utilization of cutting-edge imaging techniques in medicine was unveiled. Such a method will be developed for the cancer treatment by a team of nine world-leading imaging centers from the UK.

The NCITA (the National Cancer Imaging Translational Accelerator) sets infrastructure for implementing and adopting cancer imaging biomarkers as decision-making methods. It will be used in the NHS practice and clinical trials.

The Royal Marsden NHS Foundation Trust and the Institute of Cancer Research will join this fantastic new project. The results will offer clinical researchers from across the UK, new possibilities to world-class clinical imaging expertise and services. They will also get a new repository data management facility, continuous training chances, and AI (Artificial Intelligence) tools.

New cancer imaging network is under works

The NCITA team, after a commitment to NHS Trusts, medical imaging, pharmaceutical industries, nuclear medicine companies, patient groups, and funding parts, intends to establish new boundaries. It will develop a firm and durable imaging biomarker certification process. Such a thing will change the accuracy and speed of cancer diagnosis, patient response to treatment, and tumor classification.

“We are delighted to be part of NCITA and are working collaboratively to undertake a multicenter imaging study using whole-body MRI in patients with multiple myeloma,” stated Professor Dow-Mu Koh. The professor is also a Consultant Radiologist at The Royal Marsden NHS Foundation Trust, who co-leads the NCITA Project.

Other institutions that are part of NCITA are the University of Oxford, the University of Manchester, the University College London, the Cambridge University, the University of Glasgow, the King’s College London, the Newcastle University, and ultimately, the Imperial College London.

The new cancer imaging project will receive £10 million and is funded by Cancer Research UK. The investigators intend to bring and expand new academic and industrial partnerships as NCITA establishes.

You May Also Like

Leave a Reply

Your email address will not be published. Required fields are marked *